Charles Schwab’s Vitamin Cottage Natural Grocers NGVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Sell
90,063
-3,252
-3% -$84K ﹤0.01% 2668
2025
Q4
$2.34M Sell
93,315
-54
-0.1% -$1.73K ﹤0.01% 2714
2025
Q3
$3.73M Buy
93,369
+56,770
+155% +$2.19M ﹤0.01% 2554
2025
Q2
$1.44M Buy
36,599
+9,236
+34% +$428K ﹤0.01% 2776
2025
Q1
$1.1M Hold
27,363
﹤0.01% 2802
2024
Q4
$1.09M Buy
27,363
+974
+4% +$33.7K ﹤0.01% 2884
2024
Q3
$783K Sell
26,389
-1,083
-4% -$27.5K ﹤0.01% 2998
2024
Q2
$582K Buy
27,472
+2,891
+12% +$55K ﹤0.01% 3129
2024
Q1
$444K Sell
24,581
-1,629
-6% -$26.2K ﹤0.01% 3073
2023
Q4
$419K Hold
26,210
﹤0.01% 3142
2023
Q3
$338K Hold
26,210
﹤0.01% 3195
2023
Q2
$321K Hold
26,210
﹤0.01% 3209
2023
Q1
$308K Buy
26,210
+1,344
+5% +$13.9K ﹤0.01% 3085
2022
Q4
$227K Hold
24,866
﹤0.01% 3161
2022
Q3
$269K Buy
24,866
+45
+0.2% +$668 ﹤0.01% 3128
2022
Q2
$396K Sell
24,821
-1,300
-5% -$24.2K ﹤0.01% 3140
2022
Q1
$512K Buy
26,121
+6,827
+35% +$113K ﹤0.01% 3098
2021
Q4
$275K Hold
19,294
﹤0.01% 3299
2021
Q3
$217K Sell
19,294
-52,629
-73% -$585K ﹤0.01% 3314
2021
Q2
$773K Sell
71,923
-3,229
-4% -$43.7K ﹤0.01% 3018
2021
Q1
$1.32M Sell
75,152
-2,800
-4% -$44.2K ﹤0.01% 2766
2020
Q4
$1.07M Buy
77,952
+6,255
+9% +$77.9K ﹤0.01% 2750
2020
Q3
$707K Buy
71,697
+16,553
+30% +$217K ﹤0.01% 2776
2020
Q2
$821K Sell
55,144
-15,537
-22% -$189K ﹤0.01% 2686
2020
Q1
$602K Sell
70,681
-45,363
-39% -$390K ﹤0.01% 2650
2019
Q4
$1.15M Buy
116,044
+550
+0.5% +$5.05K ﹤0.01% 2552
2019
Q3
$1.15M Buy
115,494
+15,830
+16% +$157K ﹤0.01% 2529
2019
Q2
$1M Buy
99,664
+54,036
+118% +$619K ﹤0.01% 2574
2019
Q1
$546K Buy
45,628
+711
+2% +$10K ﹤0.01% 2733
2018
Q4
$689K Buy
44,917
+5,467
+14% +$96.6K ﹤0.01% 2655
2018
Q3
$667K Buy
39,450
+7,926
+25% +$132K ﹤0.01% 2745
2018
Q2
$402K Buy
31,524
+1,032
+3% +$9.97K ﹤0.01% 2866
2018
Q1
$219K Buy
30,492
+936
+3% +$7.17K ﹤0.01% 2964
2017
Q4
$264K Buy
29,556
+1,248
+4% +$8.21K ﹤0.01% 2917
2017
Q3
$158K Buy
28,308
+1,392
+5% +$9.31K ﹤0.01% 3040
2017
Q2
$223K Buy
26,916
+11,603
+76% +$114K ﹤0.01% 2993
2017
Q1
$160K Buy
15,313
+171
+1% +$2.04K ﹤0.01% 2963
2016
Q4
$181K Buy
15,142
+154
+1% +$1.83K ﹤0.01% 2981
2016
Q3
$168K Sell
14,988
-10,730
-42% -$133K ﹤0.01% 2951
2016
Q2
$336K Buy
25,718
+420
+2% +$6.2K ﹤0.01% 2744
2016
Q1
$539K Buy
25,298
+510
+2% +$10.3K ﹤0.01% 2549
2015
Q4
$505K Buy
24,788
+650
+3% +$14.4K ﹤0.01% 2640
2015
Q3
$548K Buy
24,138
+1,709
+8% +$41K ﹤0.01% 2586
2015
Q2
$553K Buy
22,429
+738
+3% +$18.9K ﹤0.01% 2639
2015
Q1
$599K Buy
21,691
+1,044
+5% +$29.7K ﹤0.01% 2568
2014
Q4
$582K Buy
20,647
+549
+3% +$11.4K ﹤0.01% 2560
2014
Q3
$328K Buy
20,098
+459
+2% +$9.24K ﹤0.01% 2757
2014
Q2
$421K Sell
19,639
-144
-0.7% -$3.96K ﹤0.01% 2704
2014
Q1
$864K Buy
19,783
+540
+3% +$22K ﹤0.01% 2361
2013
Q4
$817K Buy
19,243
+648
+3% +$24.9K ﹤0.01% 2363
2013
Q3
$717K Buy
18,595
+873
+5% +$31.9K ﹤0.01% 2384
2013
Q2
$571K Buy
+17,722
New +$480K ﹤0.01% 2463

Other funds holding NGVC

Charles Schwab's NGVC Position: Q1 2026 in Review

Charles Schwab reduced its Vitamin Cottage Natural Grocers (NGVC) stake by 3.5% in Q1 2026, selling an estimated $84K and leaving 90,063 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2668.

Charles Schwab first reported a position in NGVC in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.73M in Q3 2025. 155 funds tracked by Wall St. Rank hold NGVC as of Q1 2026.

  • Charles Schwab held 90,063 shares of Vitamin Cottage Natural Grocers worth $2.33M as of Q1 2026.
  • Charles Schwab sold 3,252 Vitamin Cottage Natural Grocers shares in Q1 2026, an estimated $84K.
  • Vitamin Cottage Natural Grocers made up ﹤0.01% of Charles Schwab's portfolio in Q1 2026, its #2668 holding.
  • Charles Schwab first reported a position in Vitamin Cottage Natural Grocers in Q2 2013 and has held it in 52 quarters since.
  • Charles Schwab's Vitamin Cottage Natural Grocers position peaked at $3.73M in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Vitamin Cottage Natural Grocers as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.